The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marek Minarik Lucie Mináriková |
| Publication date | January 10, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |